Translation of two healthy eating and active living support programs for parents of 2-6 year old children: a parallel partially randomised preference trial protocol (the 'time for healthy habits' trial).


Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
07 May 2020
Historique:
received: 04 03 2020
accepted: 16 03 2020
entrez: 9 5 2020
pubmed: 10 5 2020
medline: 21 10 2020
Statut: epublish

Résumé

Parents are key decision makers and role models in establishing and maintaining healthy behaviours in their children. Interventions involving parents have been shown to be more effective than those that do not, but there are barriers to participation. Efficacy trials have previously been conducted on two such parent-focussed healthy eating and active living interventions with the potential to overcome these barriers - Healthy Habits (telephone-based) and Time2bHealthy (online) with promising results. Further research is now required to determine the effectiveness of these interventions in a real-world context. The Time for Healthy Habits study is a 3-arm partially randomised preference trial which aims to evaluate the effectiveness and cost-effectiveness of two theory-based programs to promote healthy eating and appropriate levels of movement behaviours (physical activity, sedentary behaviour and sleep) for parents of 2- to 6-year-old children (Healthy Habits Plus telephone-based program and Time2bHealthy online program), when compared to a comparison group receiving written materials. Participants will be recruited across five Local Health Districts in New South Wales, Australia. The partially randomised preference design initially allows for participants to decide if they wish to be randomised or opt to select their preferred intervention and has been recommended for use to test effectiveness in a real-world setting. Both interventions incorporate multiple behaviour change techniques and support parents to improve their children's healthy eating, and movement behaviours (physical activity, sedentary behaviour and sleep) and run for 12 weeks, followed by a 3-month and 9-month post-baseline follow-up. Participants will also be asked to complete a process evaluation questionnaire at the completion of the intervention (3-months post-baseline). Outcomes include fruit and vegetable intake (primary outcome), non-core food intake, weight status, physical activity, sedentary behaviour, and sleep habits. To our knowledge, this is the first translational research trial evaluating the effectiveness and cost-effectiveness of a healthy eating and active living intervention in the 2- to 6-years age group. The results will build the evidence base in regard to translation of effective childhood obesity prevention interventions and inform the implementation and delivery of community based childhood obesity prevention programs. UTN: U1111-1228-9748, ACTRN: 12619000396123p.

Sections du résumé

BACKGROUND BACKGROUND
Parents are key decision makers and role models in establishing and maintaining healthy behaviours in their children. Interventions involving parents have been shown to be more effective than those that do not, but there are barriers to participation. Efficacy trials have previously been conducted on two such parent-focussed healthy eating and active living interventions with the potential to overcome these barriers - Healthy Habits (telephone-based) and Time2bHealthy (online) with promising results. Further research is now required to determine the effectiveness of these interventions in a real-world context. The Time for Healthy Habits study is a 3-arm partially randomised preference trial which aims to evaluate the effectiveness and cost-effectiveness of two theory-based programs to promote healthy eating and appropriate levels of movement behaviours (physical activity, sedentary behaviour and sleep) for parents of 2- to 6-year-old children (Healthy Habits Plus telephone-based program and Time2bHealthy online program), when compared to a comparison group receiving written materials.
METHODS METHODS
Participants will be recruited across five Local Health Districts in New South Wales, Australia. The partially randomised preference design initially allows for participants to decide if they wish to be randomised or opt to select their preferred intervention and has been recommended for use to test effectiveness in a real-world setting. Both interventions incorporate multiple behaviour change techniques and support parents to improve their children's healthy eating, and movement behaviours (physical activity, sedentary behaviour and sleep) and run for 12 weeks, followed by a 3-month and 9-month post-baseline follow-up. Participants will also be asked to complete a process evaluation questionnaire at the completion of the intervention (3-months post-baseline). Outcomes include fruit and vegetable intake (primary outcome), non-core food intake, weight status, physical activity, sedentary behaviour, and sleep habits.
DISCUSSION CONCLUSIONS
To our knowledge, this is the first translational research trial evaluating the effectiveness and cost-effectiveness of a healthy eating and active living intervention in the 2- to 6-years age group. The results will build the evidence base in regard to translation of effective childhood obesity prevention interventions and inform the implementation and delivery of community based childhood obesity prevention programs.
TRIAL REGISTRATION BACKGROUND
UTN: U1111-1228-9748, ACTRN: 12619000396123p.

Identifiants

pubmed: 32381052
doi: 10.1186/s12889-020-08526-7
pii: 10.1186/s12889-020-08526-7
pmc: PMC7204000
doi:

Types de publication

Clinical Trial Protocol Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

636

Références

Cochrane Database Syst Rev. 2019 Mar 07;3:CD001872
pubmed: 30843601
J Am Diet Assoc. 2003 Mar;103(3):317-22
pubmed: 12616252
BMC Public Health. 2014 Feb 10;14:140
pubmed: 24512080
BMJ. 1989 Jul 29;299(6694):313-5
pubmed: 2504416
Am J Clin Nutr. 2012 Jul;96(1):102-10
pubmed: 22623749
J Dev Behav Pediatr. 2014 Jul-Aug;35(6):378-87
pubmed: 25007060
BMC Public Health. 2010 Apr 28;10:216
pubmed: 20423524
Obes Rev. 2019 Jul;20(7):964-982
pubmed: 30868745
Ann Intern Med. 2013 Feb 5;158(3):200-7
pubmed: 23295957
J Med Internet Res. 2019 Feb 08;21(2):e11964
pubmed: 30735139
Clin Psychol Rev. 2007 Mar;27(2):240-9
pubmed: 17070638
Soc Sci Med. 2014 Aug;114:103-12
pubmed: 24922607
BMJ. 2015 May 08;350:h2147
pubmed: 25956159
J Child Health Care. 2008 Dec;12(4):329-43
pubmed: 19052190
Am J Community Psychol. 2009 Jun;43(3-4):267-76
pubmed: 19390961
Eval Health Prof. 2006 Jun;29(2):219-45
pubmed: 16645185
J Health Popul Nutr. 2012 Dec;30(4):439-46
pubmed: 23304910
BMC Public Health. 2017 Nov 29;17(1):918
pubmed: 29187157
Obes Rev. 2016 May;17(5):412-28
pubmed: 27005942
J Nutr Educ. 2001 Mar-Apr;33(2):102-7
pubmed: 12031190
BMJ. 1998 Jan 31;316(7128):360
pubmed: 9487173
Contraception. 2015 Mar;91(3):185-92
pubmed: 25500324
BMC Public Health. 2018 Mar 13;18(1):347
pubmed: 29534700
J Transcult Nurs. 2018 Jul;29(4):335-345
pubmed: 28826382
BMC Public Health. 2014 Jun 17;14:614
pubmed: 24938729
BMJ. 2008 Oct 31;337:a1864
pubmed: 18977792
Pharmacoeconomics. 2011 Jul;29(7):563-77
pubmed: 21671686
Annu Rev Public Health. 2002;23:377-401
pubmed: 11910068
Curr Opin Endocrinol Diabetes Obes. 2015 Feb;22(1):41-7
pubmed: 25517022
Int J Pediatr Obes. 2007;2(2):73-85
pubmed: 17763014
J Hum Nutr Diet. 2005 Dec;18(6):431-43
pubmed: 16351702
Int J Obes (Lond). 2019 Jan;43(1):91-102
pubmed: 30076372
Lancet. 2014 Aug 30;384(9945):766-81
pubmed: 24880830
Pediatrics. 2012 Dec;130(6):e1647-71
pubmed: 23166346
Int J Epidemiol. 2015 Dec;44(6):2006-19
pubmed: 26377509
Health Econ. 1996 May-Jun;5(3):241-7
pubmed: 8817298
Int J Pediatr Obes. 2009;4(4):257-65
pubmed: 19922040
Health Psychol. 2008 May;27(3):379-87
pubmed: 18624603
Public Health Res Pract. 2019 Mar 6;29(1):
pubmed: 30972409
Public Health Nutr. 2011 Dec;14(12):2245-53
pubmed: 21729470
Int J Behav Nutr Phys Act. 2015 Sep 17;12:118
pubmed: 26381609
Am J Clin Nutr. 2014 Mar;99(3):543-50
pubmed: 24429539
Sleep Health. 2017 Jun;3(3):136-141
pubmed: 28526249
Int J Behav Nutr Phys Act. 2008 Apr 28;5:23
pubmed: 18442392
Transl Behav Med. 2016 Mar;6(1):73-80
pubmed: 27012255
BMC Public Health. 2016 Aug 08;16:748
pubmed: 27502184
Health Educ Res. 2007 Apr;22(2):203-26
pubmed: 16861362
Contemp Clin Trials. 2017 Oct;61:73-80
pubmed: 28739536
Prev Med. 2014 Oct;67:221-37
pubmed: 25084562
PLoS One. 2015 Mar 09;10(3):e0115544
pubmed: 25751629
BMC Public Health. 2015 Jul 14;15:652
pubmed: 26169687
J Ment Health. 2018 Aug;27(4):336-344
pubmed: 29271276

Auteurs

Megan L Hammersley (ML)

Early Start, Faculty of Social Sciences, University of Wollongong, Northfields Ave, Wollongong, NSW, 2522, Australia. mhammers@uow.edu.au.
Illawarra Health and Medical Research Institute, Northfields Ave, Wollongong, NSW, 2522, Australia. mhammers@uow.edu.au.

Rebecca J Wyse (RJ)

School of Medicine and Public Health, University of Newcastle, University Drive, Callaghan, NSW, 2308, Australia.
Hunter New England Population Health, Locked Bag 10, Wallsend, NSW, 2287, Australia.
Hunter Medical Research Institute, 1/Kookaburra Circuit, New Lambton Heights, NSW, 2305, Australia.
Priority Research Centre for Heath Behaviour, University of Newcastle, University Drive, Callaghan, NSW, 2308, Australia.

Rachel A Jones (RA)

Early Start, Faculty of Social Sciences, University of Wollongong, Northfields Ave, Wollongong, NSW, 2522, Australia.

Luke Wolfenden (L)

School of Medicine and Public Health, University of Newcastle, University Drive, Callaghan, NSW, 2308, Australia.
Hunter New England Population Health, Locked Bag 10, Wallsend, NSW, 2287, Australia.
Hunter Medical Research Institute, 1/Kookaburra Circuit, New Lambton Heights, NSW, 2305, Australia.
Priority Research Centre for Heath Behaviour, University of Newcastle, University Drive, Callaghan, NSW, 2308, Australia.

Serene Yoong (S)

School of Medicine and Public Health, University of Newcastle, University Drive, Callaghan, NSW, 2308, Australia.
Hunter New England Population Health, Locked Bag 10, Wallsend, NSW, 2287, Australia.
Hunter Medical Research Institute, 1/Kookaburra Circuit, New Lambton Heights, NSW, 2305, Australia.
Priority Research Centre for Heath Behaviour, University of Newcastle, University Drive, Callaghan, NSW, 2308, Australia.

Fiona Stacey (F)

School of Medicine and Public Health, University of Newcastle, University Drive, Callaghan, NSW, 2308, Australia.
Hunter Medical Research Institute, 1/Kookaburra Circuit, New Lambton Heights, NSW, 2305, Australia.
Priority Research Centre for Heath Behaviour, University of Newcastle, University Drive, Callaghan, NSW, 2308, Australia.

Simon Eckermann (S)

Australian Health Services Research Institute, University of Wollongong, Northfields Ave, Wollongong, NSW, 2522, Australia.

Anthony D Okely (AD)

Early Start, Faculty of Social Sciences, University of Wollongong, Northfields Ave, Wollongong, NSW, 2522, Australia.
Illawarra Health and Medical Research Institute, Northfields Ave, Wollongong, NSW, 2522, Australia.

Christine Innes-Hughes (C)

NSW Office of Preventive Health, Liverpool Hospital, Locked Bag 7103, Liverpool BC, Sydney, NSW, Australia.

Vincy Li (V)

NSW Office of Preventive Health, Liverpool Hospital, Locked Bag 7103, Liverpool BC, Sydney, NSW, Australia.

Amanda Green (A)

NSW Office of Preventive Health, Liverpool Hospital, Locked Bag 7103, Liverpool BC, Sydney, NSW, Australia.

Christine May (C)

Formerly Murrumbidgee Local Health District, Cootamundra Health Service, McKay St, Cootamundra, NSW, Australia.

Joe Xu (J)

NSW Office of Preventive Health, Liverpool Hospital, Locked Bag 7103, Liverpool BC, Sydney, NSW, Australia.

Chris Rissel (C)

NSW Office of Preventive Health, Liverpool Hospital, Locked Bag 7103, Liverpool BC, Sydney, NSW, Australia.
Sydney School of Public Health, University of Sydney, Sydney, NSW, 2006, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH